olpadronic acid has been researched along with Breast Neoplasms in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (50.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Berenson, J; Hortobagyi, G; Lipton, A; Major, PP | 1 |
| Dunlop, DJ; McEwan, HP; Soukop, M | 1 |
1 review(s) available for olpadronic acid and Breast Neoplasms
| Article | Year |
|---|---|
Oral bisphosphonates: A review of clinical use in patients with bone metastases.
Topics: Alendronate; Biological Availability; Bone Density; Bone Neoplasms; Bone Resorption; Breast Neoplasms; Calcium; Clodronic Acid; Diphosphonates; Double-Blind Method; Etidronic Acid; Humans; Ibandronic Acid; Imidazoles; Male; Multiple Myeloma; Pamidronate; Prostatic Neoplasms; Pyridines; Randomized Controlled Trials as Topic; Risedronic Acid; Zoledronic Acid | 2000 |
1 other study(ies) available for olpadronic acid and Breast Neoplasms
| Article | Year |
|---|---|
Antenatal administration of aminopropylidene diphosphonate.
Topics: Adult; Breast Neoplasms; Diphosphonates; Female; Humans; Hypercalcemia; Pregnancy; Pregnancy Complications, Hematologic; Pregnancy Complications, Neoplastic | 1990 |